Positioning Early Phase CNS Trials for Investor Success
- Strategically Expanding FIH to Generate Early Proof-of-Concept Signals
- Blended Phase 1b Designs vs. Traditional Sequential Development
- Regulatory Considerations, Data Requirements, and Case Study Insights